Search Results for "Ab Biodisk Solna"
Original Source: AB BIODISK
The AB BIODISK name, company spirit and reputation are based on commitment to the highest standards of science. The company is perhaps best known for its dedication to antimicrobial resistance testing since the early 1950s. The mission left by its scientific founder, Hans Ericsson, Professor of Microbiology at the Karolinska Institute, “to Promote the Rational Use of Antibiotics” has been faithfully pursued for over 50 years.AB BIODISK develops new product concepts and processes for manufacturing unique...
Matching Channels
None
Matching News
Recipharm Expands Analytical Development Services
Adds significant capacity at Solna facility
Recipharm to expand its facility in Solna, Sweden
Adding capacity in analytical services and stability studies
Recipharm To Provide Parenteral Veterinary Product
Development and manufacture to take place at Solna and Monts sites
Regulatory News: At the annual general meeting (AGM) on May 7, 2013, of Meda AB (publ)(STO:MEDAA), corporate ID 556427-2812, Box 906, SE-170 09 Solna, Sweden, declared a dividend of 2,25 SEK per s...
Recipharm adds analytical capacity at Swedish plant
Swedish CMO Recipharm has added capacity for analytical services and stability studies at its laboratory in Solna, Sweden
Recipharm invests in analytical development services
Recipharm, a contract development and manufacturing organization based in Sweden, has invested in expanding its capacity in analytical services and stability studies at its facility in Solna, Sweden.
Recipharm enters into a new development and manufacturing collaboration with Vetcare
Recipharm and Vetcare have announced the signing of an agreement for the development and manufacture of a parenteral veterinary product. Specifically, the product concerned will be developed by Reciph...
Recipharm and Astimex Pharma form new development and manufacturing collaboration
Recipharm AB and Astimex Pharma AB have today announced the formation of a collaboration agreement for the development and manufacture of a pharmaceutical product. The formulation development work wil...
Matching PubMed Articles
Immunogenicity of delayed TBE-vaccine booster.
Information is scarce regarding the antibody response when TBE-vaccine booster doses are delayed, which is a common situation in daily life. We have investigated the immune response after a delayed bo...
Low persistence of anticholinergic drug use in Sweden.
Quest for genes and mechanisms linking the human chromosome 9p21.3 locus to cardiovascular disease.
An immune response to an antigen is more efficiently induced in combination with an adjuvant. Chitosan has due to documented immunostimulatory characteristics been proposed as an adjuvant candidate. H...
